Activation of Ca2+-activated potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells

Atherosclerosis

Volumn 190, Issue 1, 2007, Pages 100-105

  Erdogan, Ali ^a   Schaefer, Martina Barbara ^b   Kuhlmann, Christoph Ruediger Wolfram ^a   Most, Astrid ^a   Hartmann, Marc ^a   Mayer, Konstantin ^b   Renner, Fabrice Christoph ^b   Schaefer, Claudia ^a   Abdallah, Yaser ^a   Hoelschermann, Hans ^a   Schaefer, Christian Alexander ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Adhesion; Endothelial cells; LPC; Membrane potential; Potassium channel

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; CALCIUM ACTIVATED POTASSIUM CHANNEL; DIPHENYLIODONIUM SALT; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FLUORESCENT DYE; IBERIOTOXIN; INTERCELLULAR ADHESION MOLECULE 1; LYSOPHOSPHATIDYLCHOLINE; VASCULAR CELL ADHESION MOLECULE 1; CALCIUM; CATION; ENZYME INHIBITOR; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; PEPTIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CELL ADHESION; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MEMBRANE POTENTIAL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ATHEROSCLEROSIS; CELL STRAIN U937; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULITIS;

ATHEROSCLEROSIS; CALCIUM; CELL ADHESION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LYSOPHOSPHATIDYLCHOLINES; MONOCYTES; NADPH OXIDASE; ONIUM COMPOUNDS; PEPTIDES; REACTIVE OXYGEN SPECIES; U937 CELLS; UMBILICAL VEINS; VASCULITIS;

EID: 33845453305     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.02.035     Document Type: Article

References (34)

1. Ross R. Mechanisms of disease: atherosclerosis-an inflammatory disease. New Engl J Med 340 (1999) 115-126
2. Aikawa M., Sugiyama S., Hill C.C., et al. Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation 106 11 (2002) 1390-1396
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 6423 (1993) 801-809
4. Caplan B.A., and Schwartz C.J. Increased endothelial cell turnover in areas of in vivo Evans blue uptake in pig aorta. Atherosclerosis 17 (1973) 401-417
5. Crisby M., Kallin B., Thyberg J., et al. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 130 1-2 (1997) 17-27
6. Rosenfeld M.E. Oxidized LDL affects multiple atherogenic cellular responses. Circulation 83 (1991) 2137-2140
7. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogenicity. New Engl J Med 320 (1989) 915-924
8. Witztum J.L. Role of oxidized low density lipoprotein in atherogenesis. Br Heart J 69 (1993) 12-18
9. Heinloth A., Heermeier K., Raff U., Wanner C., and Galle J. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J Am Soc Nephrol 118 (2000) 1819-1825
10. Wu R., Huang Y.H., Elinder L.S., and Frostegard J. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL. Arterioscler Thromb Vasc Biol 18 (1998) 626-630
11. Galle J., Mulsch A., Busse R., and Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arterioscler Thromb Vasc Biol 11 (1991) 198-203
12. Nilius B., and Droogmans G. Ion channels and their functional role in vascular endothelium. Phys Rev 81 (2001) 1415-1459
13. Adams D.J., Barakeh J., Laskey R., and van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB 3 (1989) 2389-2400
14. + channels contributes to ROS dependent proliferation of cultured human endothelial cells. J Mol Cell Cardiol 36 (2004) 675-682
15. Jaffe E.A., Nachmann R.K., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical vein. Identification by morphologic and immunologic criteria. J Clin Invest 52 (1973) 2745-2756
16. Marrack P., Skidmore B., and Kappler J.W. Binding of antigen-specific H-2-restricted T cell hybridomas to antigen-pulsed adherent cell monolayers. J Immunol 130 (1983) 2088-2092
17. Kim I., Moon S.O., Kim S.H., et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB activation in endothelial cells. J Biol Chem 276 (2001) 7614-7620
18. Kuhlmann C.R., Trumper J.R., Abdallah Y., et al. The K+-channel opener NS1619 increases endothelial NO-synthesis involving p42/p44 MAP-kinase. Thromb Haemost 92 5 (2004) 1099-1107
19. Langheinrich U., and Daut J. Hyperpolarization of isolated capillaries from guineapig heart induced by K+ channel openers and glucose deprivation. J Physiol 502 (1997) 397-408
20. Chen Y., Chen H., and Wu L. Effect of lysophosphatidylcholine on endothelial cell surface expression of adhesion molecules. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 17 2 (2000) 139-142 ["Abstract". Article in Chinese]
21. Cominacini L., Pasini A., Garbin U., et al. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species. Am J Hypertens 15 10 Pt 1 (2002) 891-895
22. Cominacini L., Garbin U., Pasini A.F., et al. The expression of adhesion molecules on endothelial cells is inhibited by troglitazone through its antioxidant activity. Cell Adhes Commun 7 3 (1999) 223-231
23. Khan B.V., Parthasarathy S.S., Alexander R.W., and Medford R.M. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95 3 (1995) 1262-1270
24. Kume N., Cybulsky M.I., and Gimbrone Jr. M.A. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90 3 (1992) 1138-1144
25. Sugiyama S., Kugiyama K., Ohgushi M., Fujimoto K., and Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. Circ Res 74 4 (1994) 565-575
26. Jeng J.R., Chang C.H., Shieh S.M., and Chiu H.C. Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment. Biochim Biophys Acta 1178 2 (1993) 221-227
27. Frostegard J., Nilsson J., Haegerstrand A., et al. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 87 3 (1990) 904-908
28. Erl W., Weber P.C., and Weber C. Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis 136 2 (1998) 297-303
29. Frostegard J., Wu R., Haegerstrand A., et al. Mononuclear leukocytes exposed to oxidized low density lipoprotein secrete a factor that stimulates endothelial cells to express adhesion molecules. Atherosclerosis 103 2 (1993) 213-219
30. Cominacini L., Pasini A.F., Garbin U., et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275 17 (2000) 12633-12638
31. Zhu Y., Lin J.H., Liao H.L., Verna L., and Stemerman M.B. Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases. Biochim Biophys Acta 1345 1 (1997) 93-98
32. Sonoki K., Iwase M., lino K., et al. Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor. Metabolism 52 3 (2003) 308-314
33. den Hertog J., Groen A., and van der Wijk T. Redox regulation of protein-tyrosine phosphatases. Arch Biochem Biophys 434 1 (2005) 11-15
34. Nakashima I., Takeda K., Kawamoto Y., et al. Redox control of catalytic activities of membrane-associated protein tyrosine kinases. Arch Biochem Biophys 434 1 (2005) 3-10